En pacientes con diabetes tipo 2, en comparacin con placebo, semaglutida logr las siguientes reducciones relativas de glucagn: glucagn en ayuno (8-21%), respuesta de glucagn postprandial (14- 15%) y concentracin media de glucagn a las 24 horas (12%)
For instance, Ozempic helps reduce the risk of serious cardiovascular events, such as heart attacks, strokes, and cardiovascular-related deaths, in adults with type 2 diabetes
Tirzepatide (a dual GIP/GLP-1 medication, injected weekly) has produced higher average weight loss in trials, often near or above 20% depending on the dose and study
Try this: Smaller meals more frequently (mini meals beat giant feasts) Protein + bland carbs (turkey + roll, yogurt + toast) Ginger tea or ginger chews Hydration throughout the day Stop eating at comfortable , not full Red flag: persistent vomiting, inability to keep fluids down, severe abdominal paincontact your prescriber urgently
The importance of weight management in type 2 diabetes mellitus